Explore a little further

Merck

Stories and perspectives from Daytrade News.

From Daytrade News

6 stories shown · Newest added
Daytrade News

Moderna Shares Recover After Decline Following Cancer Vaccine Success

Moderna's shares rose by 2.9% in pre-market trading as they rebounded from a recent decline. This follows a significant rally triggered by positive Phase 3 trial results for its personalized mRNA cancer vaccine, intismeran autogene, which showed a reduction in melanoma recurrenc…

More perspectives

Across our publications

A selection of related stories